Brief: Diamyd Medical To Pursue Accelerated Approval Pathway For Type 1 Diabetes Precision Medicine

Diamyd Medical AB

09/09/2024 07:59

Sept 9 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * TO PURSUE ACCELERATED APPROVAL PATHWAY FOR TYPE 1 DIABETES
PRECISION MEDICINE
    * RESULTS FROM INTERIM READOUT ARE EXPECTED AROUND MARCH
2026

Source text for Eikon:  ID:nWkr35G3KN 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))